Back to today’s briefing

Story perspectives

Ozempic: Promising Solution for Fatty Liver Disease?

1/24/2025

31 7

Summary

Story summary

Ozempic, originally designed for type 2 diabetes, is emerging as a potential game-changer for fatty liver disease, effectively reducing liver fat and enhancing insulin sensitivity. However, it remains unapproved by the FDA for this purpose, and insurance coverage is scarce. Patients must also consider possible side effects, ranging from digestive troubles to more serious health concerns.

1 of 1

Story summary

Ozempic, originally designed for type 2 diabetes, is emerging as a potential game-changer for fatty liver disease, effectively reducing liver fat and enhancing insulin sensitivity. However, it remains unapproved by the FDA for this purpose, and insurance coverage is scarce. Patients must also consider possible side effects, ranging from digestive troubles to more serious health concerns.